The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 1.

Table. 1.

Transfusion indications according to the blood components

Blood componentsTransfusion indications
RBCs  - WB, PRBC, FRBC, WRBC1. Acute bleeding
□ 1.1. ≥1500 mL or ≥30% (of total body blood volume) bleeding
□ 1.2. Ongoing bleeding
2. Chronic anemia
□ 2.1. Hb ≤7 g/dL
□ 2.2. Hb >7 g/dL, but underlying clinical conditions that need transfusion
 □ 2.2.1. Cardiovascular disease
 □ 2.2.2. Cerebrovascular disease
 □ 2.2.3. Peripheral vascular disease
 □ 2.2.4. Respiratory disease
 □ 2.2.5. Age ≥65 yrs
 □ 2.2.6. Age ≤6 months
3. Surgery/procedure-related transfusion
□ 3.1. Hb ≤8 g/dL
□ 3.2. Hb >8 g/dL, but accompanying cardiovascular, respiratory or cerebrovascular diseases
4. Transplantation-related transfusion
□ 4.1. Liver transplantation
□ 4.2. Kidney transplantation
□ 4.3. Peripheral blood stem cell transplantation (PBSCT)
5. Others
□ 5.1. Other ________________________________
Platelets  - PC, SDP1. Bleeding
□ 1.1. Active bleeding: for maintaining PLT ≥50,000/μL
□ 1.2. Retinal bleeding, multiple trauma, central nervous system (CNS) injury: for PLT: ≥100,000/μL
2. Bleeding prophylaxis
2.1. Hematologic disease
 □ 2.1.1. Stable state: for PLT ≥10,000/μL
 □ 2.1.2. Unstable state(fever, sepsis, etc): for PLT ≥20,000/μL
2.2. Solid tumor
 □ 2.2.1. Stable state: for PLT ≥10,000/μL
 □ 2.2.2. ↑Bleeding risk (tumor with necrosis, etc): for PLT ≥20,000/μL
2.3. PBSCT
 □ For PLT ≥20,000/μL
2.4. Disseminated intravascular coagulopathy (DIC)
 □ For PLT ≥50,000/μL (neonate: ≥100,000/μL)
2.5. Infant
 □ 2.5.1. Stable state: for PLT ≥30,000/μL
 □ 2.5.2. Unstable state: for PLT ≥50,000/μL
 □ 2.5.3. Extracorporeal membrane oxygenation (ECMO): for PLT ≥100,000/μL
3. Surgery/procedure-related transfusion
□ 3.1. Elective surgery, lumbar puncture, thoracentesis/paracentesis, fine needle aspiration, odontectomy, delivery, transbronchial lung biopsy, liver biopsy, central venous line insertion, cardiopulmonary bypass surgery: for PLT ≥50,000/μL
□ 3.2. Epidural anesthesia: for PLT ≥80,000/μL
□ 3.3. CNS surgery, complex cardiovascular surgery, etc: for PLT: ≥100,000/μL
4. Massive transfusion
□ For PLT: ≥100,000/μL
5. Others
□ 5.1. Other _____________________________________________________
 FFP1. Bleeding in coagulopathy
□ 1.1. DIC
□ 1.2. Liver disease
□ 1.3. Coumarin use
□ 1.4. Abnormal coagulation test results (PT, aPTT, fibrinogen, etc)
2. Bleeding prophylaxis in coagulopathy
□ 1.1. DIC
□ 1.2. Liver disease
□ 1.3. Coumarin use
□ 1.4. Abnormal coagulation test results (PT, aPTT, fibrinogen, etc)
3. Special situations
□ 3.1. Massive transfusion
□ 3.2. Plasma exchange for Thrombotic thrombocytopenic purpura (TTP)
4. Others
□ 4.1. Other __________________________________________________________
Korean J Blood Transfus 2019;30:138-47 https://doi.org/10.17945/kjbt.2019.30.2.138
© 2019 Korean J Blood Transfus